Stock AnalizTenet Healthcare Corp. THC
Hospital/Nursing Management · data as of November 13, 2026
Tenet Healthcare Corp. (THC) is a healthcare company listed in the US with a market value of about $22.8B. In the twelve months to September 30, 2026 it had revenue of $22.2B and net income of $2.9B, a net margin of 13.1%.
Its overall Stock Analiz score is 2.8 out of 5 (average). The strongest part is value (5/5); the weakest is future growth (1/5).
Key numbers: a P/E of 8.3, a price to free cash flow of 6.8, 5-year revenue growth of 4% a year, a 5-year average ROIC of 15%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 31% above the current price.
Score: 2.8 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Checks not passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Interest covered more than 5 times
- Debt below 3 years of free cash flow
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.2B | $21.3B | $20.7B | $20.6B | $19.2B | $19.5B | $17.6B | $18.5B | $18.3B | $20.6B | $21.1B |
| Net income | $2.9B | $1.4B | $3.2B | $611M | $411M | $914M | $399M | -$215M | $104M | -$704M | -$192M |
| Free cash flow | $3.3B | $2.5B | $1.1B | $1.6B | $321M | $910M | $2.9B | $563M | $432M | $493M | -$317M |
| EPS (diluted) | $34.47 | $15.49 | $32.70 | $5.71 | $3.79 | $8.42 | $3.75 | $-2.08 | $1.00 | $-7.00 | $-1.93 |
| Net margin | 13.1% | 6.6% | 15.5% | 3.0% | 2.1% | 4.7% | 2.3% | -1.2% | 0.6% | -3.4% | -0.9% |
| ROIC | — | 15.8% | 24.8% | 11.3% | 9.9% | 12.5% | 9.2% | 5.0% | 7.5% | 5.9% | 5.7% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 22 analysts is $306.18, 7% above the current price; targets range from $265.00 to $342.00; the consensus rating is “Buy”; expected EPS is $22.71 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Tenet Healthcare’s P/E ratio?
About 8.3, based on the last twelve months of diluted earnings per share (forward P/E about 14.3).
Is Tenet Healthcare stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 31% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Tenet Healthcare pay a dividend?
Not currently.
Is Tenet Healthcare a good stock to buy?
We do not give buy or sell advice. Tenet Healthcare scores 2.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.